HIT Consultant September 7, 2022
Sobha Pisharody, PhD, Chief Strategy & Product Officer, InformedDNA

Pharmacogenomics—the study of genetic influences on an individual’s response to therapeutic medications—is an area of personalized medicine that is gaining momentum. Although pharmacogenomics has been around for a while, providers, health plans, pharmacists and legislators are developing a greater appreciation for its potential benefits and applications.

How Can Pharmacogenomics Improve Outcomes?

By considering a person’s DNA in treatment options, providers can determine how an individual’s genetic profile may impact the way the individual could respond to specific therapies. For example, certain gene changes may indicate a person is a high metabolizer and thus may require a higher starting dose of medication to have a therapeutic effect. Alternatively, other gene changes may indicate a low metabolizer status, which may indicate...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Interview / Q&A, Pharma / Biotech, Precision Medicine, Trends
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
Precision medicine approach combining AI, DNA and drug testing shows gains against relapsed childhood cancers

Share This Article